Inovio Pharmaceuticals, Inc. (INO) Financials

INO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 193.1 million 54.9 million
2023-06-30 233.0 million 63.7 million
2023-03-31 266.6 million 67.4 million
2022-12-31 348.5 million 126.2 million

INO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -36.8 million 3.8 million
2023-06-30 -32.3 million 2.9 million
2023-03-31 -37.0 million 3.8 million
2022-12-31 -36.5 million 3.3 million

INO Net Income

No data available :(

INO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 167.5 million - 13.3 million
2023-06-30 194.9 million - 14.1 million
2023-03-31 223.8 million - 14.8 million
2022-12-31 253.0 million 16.6 million 15.5 million

INO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 268.6 million
2023-06-30 264.4 million
2023-03-31 258.4 million
2022-12-31 238.6 million

INO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 15.5 million 9.9 million -
2023-06-30 23915 23.7 million 13.5 million -
2023-03-31 296983 30.2 million 13.9 million -
2022-12-31 165109 42.1 million 14.0 million -

INO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 388446 1.0 million
2023-06-30 225971 1.1 million
2023-03-31 114943 30.2 million
2022-12-31 124666 1.3 million

INO

Price: $12.10

52 week price:
3.84
14.75

Earnings Per Share: -6.09 USD

P/E Ratio: -0.70

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 3.8 million

Ebitda: -28.0 million

Market Capitalization: 269.0 million

Links: